Ziftomenib has received Breakthrough Therapy, Fast Track, and Orphan Drug Designations. The FDA has a 60-day filing review period to determine whether the NDA is complete and accepted for review; Kura ...

Kura Oncology (KURA) announced Kura submitted a New Drug Application for ziftomenib, a highly selective, once-daily, oral, investigational ...

Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel ...

Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA as the first and onl ...

Paraganglioma Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Global Panuvei ...

Killingham's Ryu Ryu no Mi, Model: Kirin is a powerful Devil Fruit revealed in One Piece. Killingham can transform into a Kirin and turn dreams into reality using his Mythical Zoan powers.

Thousand Oaks, CA-based Amgen is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular disease, inflammation, bone health and rare ...

The company's latest PC processor, Kirin X90, has received China's Level 2 national certification... Save my User ID and Password Some subscribers prefer to save their log-in information so they ...

The recent approvals and robust pipeline activity are expected to fuel the market of molecular glues in the 7MM during the forecast period 2025-2034 due to factors like improved diagnosis ...